Lymphoma
📧 Sign up to get email alerts when something new happens for Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: T-Cell Depletion, Donor Hematopoietic Stem Cell Transplant (HSCT), and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other Diseases [Phase 2]
Phase 2 study evaluating T-cell depletion and donor hematopoietic stem cell transplantation with T-cell infusions in patients with various h…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Study of Nivolumab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) That Have Either Failed or Are Not Eligible for Autologous Stem Cell Transplant (CheckMate 139) [Phase 2]
Phase 2 trial evaluating nivolumab in relapsed or refractory diffuse large B-cell lymphoma (DLBCL) after autologous stem cell transplant fai…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other Diseases [NA]
This ClinicalTrials.gov update reports on a completed study evaluating whether music can reduce anxiety and pain in adults undergoing bone m…
-
CLINICAL_TRIALS trial_result · 2017-05-11Clinical Trial Update: Effects of Anticoagulant Preventive Injection in Patients With Blood Cancer [Phase 2]
Phase 2 clinical trial evaluating an anticoagulant preventive injection in patients with lymphoma or multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Pilot Study of Lymphoid Tumor Microenvironmental Dysruption Prior to Autologous Stem Cell Transplantation [Phase 1]
A Phase 1 pilot study evaluating disruption of the lymphoid tumor microenvironment prior to autologous stem cell transplantation was termina…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant [Phase 3]
A Phase 3 trial of moxifloxacin to prevent bacterial infections in patients who have undergone a donor stem cell transplant was terminated.
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: Donor Peripheral Stem Cell Transplant, Fludarabine, and Busulfan in Treating Patients With Hematologic Cancers [Phase 2]
Phase 2 trial assessing donor peripheral stem cell transplant with fludarabine and busulfan in hematologic cancers has completed; results po…
-
CLINICAL_TRIALS trial_result · 2017-04-28Clinical Trial Update: High-dose Etoposide Could Discriminate Patients With Refractory/Relapsed Lymphoma Benefit From APBSCT
The update reports that high-dose etoposide may help discriminate which patients with refractory or relapsed lymphoma benefit from autologou…
-
CLINICAL_TRIALS trial_result · 2017-04-28Clinical Trial Update: Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies [Phase 1]
Phase 1 clinical trial update investigating cord blood fucosylation to enhance homing and engraftment in patients with hematologic malignanc…
-
CLINICAL_TRIALS trial_result · 2017-04-26Clinical Trial Update: Safety and Pharmacology Study of SNX-5422 in Subjects With Refractory Hematological Malignancies [Phase 1]
This document reports the completion of a Phase 1 safety and pharmacology study of SNX-5422 in patients with refractory hematologic malignan…
-
CLINICAL_TRIALS trial_result · 2017-04-25Clinical Trial Update: Rasburicase Treatment for Chemotherapy or Malignancy-Induced Hyperuricemia in Asthma/Allergy Patients
Completed trial evaluating rasburicase for chemotherapy- or malignancy-induced hyperuricemia in leukemia and lymphoma patients.
-
CLINICAL_TRIALS trial_result · 2017-04-21Clinical Trial Update: Melphalan With BBBD in Treating Patients With Brain Malignancies [Phase 1]
Phase 1 trial of melphalan with blood-brain barrier disruption for brain tumors and related cancers has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-04-18Clinical Trial Update: Lenalidomide After Allo Transplant [Phase 1]
A Phase 1 trial of lenalidomide after allogeneic transplant in patients with multiple myeloma or lymphoma was terminated. The update provide…
-
CLINICAL_TRIALS trial_result · 2017-04-18Clinical Trial Update: CD19 Targeted Chimeric Antigen Receptor T Cells for B Cell Lymphoma [Phase 1, Phase 2]
This update covers a Phase 1/2 trial evaluating CD19-targeted CAR-T cell therapy for lymphoma. The current status is not disclosed in the sn…
-
CLINICAL_TRIALS trial_result · 2017-04-12Clinical Trial Update: A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0425 Administered With and Without Gemcitabine in Patients With Refractory Solid Tumors or Lymphoma [Phase 1]
Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of GDC-0425 with and without gemcitabine in patients with refractory…
-
CLINICAL_TRIALS trial_result · 2017-04-11Clinical Trial Update: Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant [Phase 1]
A Phase 1 trial evaluating rasburicase to prevent graft-versus-host disease in patients undergoing donor stem cell transplantation; the stud…
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Have Not Responded to Previous Therapy [Phase 1]
This Phase 1 trial update reports on transplantation using specially treated bone marrow for hematologic cancers that have not responded to …
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: Autologous Transplant in HIV Patients (BMT CTN 0803) [Phase 2]
Phase 2 trial evaluating autologous transplant in HIV-infected patients with lymphoma; completed with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-03-24Clinical Trial Update: Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant [Phase 2]
Phase 2 trial evaluating donor stem cell transplantation for patients with relapsed hematologic malignancies or secondary myelodysplasia who…
-
CLINICAL_TRIALS trial_result · 2017-03-20Clinical Trial Update: Biosimilar Retacrit™ (Epoetin Zeta) in the Treatment of Chemotherapy-Induced Symptomatic Anaemia in Haematology and Oncology
The trial evaluating Retacrit (epoetin zeta), a biosimilar, for chemotherapy-induced symptomatic anemia in hematology and oncology has compl…
-
CLINICAL_TRIALS trial_result · 2017-03-09Clinical Trial Update: Multi-day Doses in Prevention of Nausea and Emesis [Phase 2]
Phase 2 trial evaluating multi-day dosing to prevent nausea and emesis in patients with multiple myeloma and lymphoma. The study completed a…
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Feasibility of Assessing Lymphoma Response to Precise Local Injection of Candidate Chemotherapy Agents [Phase 1]
A Phase 1 feasibility trial evaluating the ability to assess lymphoma response to precisely injected candidate chemotherapy agents has compl…
-
CLINICAL_TRIALS trial_result · 2017-02-10Clinical Trial Update: Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy [Phase 2]
Phase 2 trial evaluating epoetin alfa or darbepoetin alfa for chemotherapy-induced anemia; results from a completed study were posted in 201…
-
CLINICAL_TRIALS trial_result · 2017-02-09Clinical Trial Update: AMG 319 Lymphoid Malignancy FIH [Phase 1]
First-in-human Phase 1 clinical trial update for AMG 319 in lymphoid malignancies, including chronic lymphocytic leukemia and various lympho…
-
CLINICAL_TRIALS trial_result · 2017-02-07Clinical Trial Update: LMP2a-Specific Cytotoxic T-Lymphocytes, Lymphoma (ACDAL) [Phase 1]
Phase 1 trial of LMP2a-specific cytotoxic T-lymphocytes for lymphoma has been terminated.